Ballast Asset Management’s iRadimed IRMD Stock Holding History

Ballast Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-37,107	Closed	-$3.57M	–	55
2026 Q1	$3.57M	Buy	37,107 +870	+2%	+$87K	1.59%	34
2025 Q4	$3.53M	Sell	36,237 -1,218	-3%	-$104K	1.67%	33
2025 Q3	$2.67M	Sell	37,455 -3,459	-8%	-$230K	1.22%	41
2025 Q2	$2.45M	Hold	40,914	–	–	1.27%	37
2025 Q1	$2.15M	Buy	40,914 +594	+1%	+$33.4K	1.13%	42
2024 Q4	$2.22M	Sell	40,320 -1,388	-3%	-$73K	1.1%	41
2024 Q3	$2.1M	Sell	41,708 -592	-1%	-$27.3K	1.07%	45
2024 Q2	$1.86M	Buy	42,300 +2,548	+6%	+$108K	1.01%	46
2024 Q1	$1.75M	Buy	39,752 +3,528	+10%	+$156K	0.95%	45
2023 Q4	$1.72M	Buy	36,224 +11,136	+44%	+$468K	1.09%	45
2023 Q3	$1.11M	Buy	+25,088	New	+$1.17M	1.03%	43

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ballast Asset Management's IRMD Position: Q2 2026 in Review

Ballast Asset Management sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 37,107 shares — an estimated $3.57M sold.

Ballast Asset Management first reported a position in IRMD in Q3 2023 and held it in 11 quarters. The position peaked at $3.57M in Q1 2026. 213 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Ballast Asset Management reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
Ballast Asset Management sold 37,107 iRadimed shares in Q2 2026, an estimated $3.57M.
Ballast Asset Management first reported a position in iRadimed in Q3 2023 and held it in 11 quarters.
Ballast Asset Management's iRadimed position peaked at $3.57M in Q1 2026.
213 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Ballast Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.